Donate Today

Racial/ethnic disparities in timely receipt of buprenorphine among Medicare disability beneficiaries

Published
11/01/2023
Developed by
ICUDDR
Resource Type
Related Topics
External Link
Read more

Authors: Jennifer MilesPeter TreitlerRichard HermidaAmesika N. NyakuKosali SimonSumedha GuptaStephen CrystalHillary Samples

Medicare disability beneficiaries (MDBs) have disproportionately high risk of opioid use disorder (OUD) and related harms given high rates of comorbidities and high-dose opioid prescribing. Despite this increased risk, little is known about timely receipt of medication for opioid use disorder (MOUD), including potential disparities by patient race/ethnicity or moderation by county-level characteristics.

chevron-down